Drs. Christy Capone, Erica Eaton, and Carolina Haass-Koffler have received funding from the OVPR and the CADRE to conduct the first pilot trial of psychedelics at CAAS, under a grant entitled "Safety, feasibility, and acceptability of MDMA-assisted therapy for the treatment of co-occurring alcohol use disorders and posttraumatic stress disorder in veterans."
The research team will be evaluating MDMA-assisted therapy for military veterans with co-occurring posttraumatic stress disorder (PTSD) and alcohol use disorders. They will recruit 12 veterans with PTSD and alcohol use problems -- all will receive MDMA-assisted therapy delivered by trained therapists. The researchers hope to show that this treatment is feasible to deliver with this population, and that there is preliminary evidence of its efficacy.